16 × AIAI signal, amplified
AI newsTopicsAboutSources
TelegramFollow on Telegram
AI newsTopicsAboutSources
16 × AIAI signal, amplified

An AI news engine that ingests trusted sources, scores with Claude, and posts only what clears the bar.

Follow on Telegram →

Subscribe

  • Telegram
  • RSS
  • All channels

Newsletter

Used only to send this newsletter. Privacy

Legal

  • Privacy
  • Imprint
© 2026 16 × AI. All rights reserved.A new issue every two days.
Home/Research
Research

MIT duo wins Pritzker Prize for AI antibiotic discovery

MIT News AI·November 2, 2026·high confidence

Why it matters

  • →Validates generative AI as a primary tool for drug design rather than just analysis.
  • →Demonstrates measurable speed improvements in identifying antibiotics against superbugs.
  • →Establishes a new benchmark for interdisciplinary AI research awards in natural sciences.
MIT duo wins Pritzker Prize for AI antibiotic discovery
©MIT News AI

Regina Barzilay and James Collins of MIT have been awarded the 2026 Pritzker Prize for AI in Science Research Excellence for their pioneering work in AI-enabled antibiotic discovery. The prize honors their development of deep learning models that identified halicin and abaucin, novel antibiotics effective against drug-resistant pathogens like C. difficile and A. baumannii. Their research demonstrated that machine learning could reduce the discovery timeline from years to weeks by predicting molecular efficacy with high precision. Established in 2024, the award highlights the growing convergence of artificial intelligence and biomedical engineering.

Read original

The story around this

Earlier coverage that leads up to this article, and what followed. Lines connect each piece to the closest one after it, converging here.

Quantum Computing Boosts AI in Drug Discovery — WIRED AI1AI Revolutionizes Biologic Drug Discovery — MIT Technology Review AI2AI's Role in Transforming Drug Discovery — MIT Technology Review AI3AI Designs Novel Viruses to Combat Drug Resistance — The Rundown AI4AI Designs Novel Viruses to Combat Drug Resistance — The Rundown AI5MIT Develops PottsMPNN for Protein Design — MIT News AI6AI Tools Aid Search for Antimicrobial Molecules — OpenAI7Claude discovers novel enzyme system in DNA — Wes Roth8MIT duo wins Pritzker Prize for AI antibiotic discoveryJul 12You are here

How we got here

  1. 1
    Quantum Computing Boosts AI in Drug Discovery

    WIRED AI · July 12, 2026 · Background

  2. 2
    AI Revolutionizes Biologic Drug Discovery

    MIT Technology Review AI · July 23, 2026 · Background

  3. 3
    AI's Role in Transforming Drug Discovery

    MIT Technology Review AI · July 27, 2026 · Background

  4. 4
    AI Designs Novel Viruses to Combat Drug Resistance

    The Rundown AI · August 7, 2026 · Background

  5. 5
    AI Designs Novel Viruses to Combat Drug Resistance

    The Rundown AI · August 7, 2026 · Background

  6. 6
    MIT Develops PottsMPNN for Protein Design

    MIT News AI · August 27, 2026 · Background

  7. 7
    AI Tools Aid Search for Antimicrobial Molecules

    OpenAI · September 10, 2026 · Background

  8. 8
    Claude discovers novel enzyme system in DNA

    Wes Roth · September 24, 2026 · Background

More in Research

Albert Gu Proposes Learning Directly from Raw Data© AI Explained
Researchresearch

Albert Gu Proposes Learning Directly from Raw Data

AI researcher Albert Gu advocates for training models directly from raw data, challenging current tokenization paradigms.

AI Explained·Nov 2, 2026
Anthropic study: Agents sway expert judgment 86% of time© Cole Medin
Researchagents

Anthropic study: Agents sway expert judgment 86% of time

Anthropic’s latest research exposes a quiet but dangerous flaw in agentic workflows: experts follow AI recommendations 86% of the time, often adopting the agent's reasoning as their own. This isn't just about accuracy; it's about cognitive capture, where human oversight dissolves into passive compliance. The study shows that even when users believe they are steering, the agent’s framing dictates the outcome. Practitioners must now actively counter this bias by forcing agents to justify deviations or prototype alternatives before committing to a path. This shift demands a new discipline in how we interact with coding assistants. We can no longer assume our intent drives the result; the model's suggestion often becomes the default truth. The real work is ensuring we remain the architects, not just the approvers.

Cole Medin·Oct 31, 2026
AI-Augmented Infostealer 'Volta-Autodoxer' Targets High-Value Victims© WIRED AI
Researchother

AI-Augmented Infostealer 'Volta-Autodoxer' Targets High-Value Victims

Cisco Talos has uncovered a new infostealer strain that actively uses commercial LLMs to profile victims and prioritize high-value targets. Dubbed Volta-Autodoxer, the malware collects credentials and browsing data, then feeds this into models like Claude Opus 4.6 via OpenRouter to generate structured intelligence dossiers. This marks a shift from passive data theft to active, AI-driven triage, allowing attackers to bypass guardrails with fallback models like Kimi K2 or Gemini. The capability foreshadows a future where lower-sophistication criminals can execute sophisticated, targeted attacks at scale.

WIRED AI·Oct 31, 2026